| 标题 |
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Respiratory Medicine 作者:Tim Harrison; Pascal Chanez; Francesco Menzella; Giorgio Walter Canonica; Renaud Louis; et al 出版日期:2020-12-22 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)